Insulin Pumps

Insulin Pumps

Global Insulin Pumps Market to Reach US$28.2 Billion by 2030

The global market for Insulin Pumps estimated at US$17.4 Billion in the year 2023, is expected to reach US$28.2 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. Tethered Pumps, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$15.0 Billion by the end of the analysis period. Growth in the Patch Pumps segment is estimated at 8.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.8 Billion While China is Forecast to Grow at 6.7% CAGR

The Insulin Pumps market in the U.S. is estimated at US$4.8 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.3 Billion by the year 2030 trailing a CAGR of 6.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.3% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

Global Insulin Pumps Market - Key Trends & Drivers Summarized

What Is an Insulin Pump and How Does It Manage Diabetes?
An insulin pump is a small, computerized device that delivers insulin continuously to diabetes patients, simulating the way a healthy pancreas releases insulin. It is used primarily by individuals with Type 1 diabetes and those with Type 2 diabetes who require insulin therapy. The device eliminates the need for multiple daily injections by providing a steady, measured, and continuous dose of rapid-acting insulin through a catheter placed under the skin. In addition to the basal rate, which is the steady trickle of insulin, users can input bolus doses to manage glucose spikes during meals. This method of insulin delivery not only improves glycemic control but also enhances lifestyle flexibility and reduces the burden of managing diabetes on a daily basis.

How Are Technological Advancements Improving Insulin Pump Functionality?
Technological advancements have significantly enhanced the functionality and user-friendliness of insulin pumps. Modern pumps are increasingly integrated with Continuous Glucose Monitoring (CGM) systems, providing real-time insights into glucose levels and trends. This integration supports more precise dosing decisions and can automatically adjust insulin delivery based on CGM readings, a feature known as sensor-augmented pump therapy with predictive low-glucose suspend. Moreover, the advent of artificial pancreas systems or closed-loop systems marks a pivotal development in diabetes care. These systems automate insulin delivery to an extent that mimics a healthy pancreas by using algorithms to analyze CGM data and make pump adjustments in real time, thereby reducing user input and minimizing the risk of hypoglycemia.

What Are the Influential Trends in the Insulin Pump Industry?
Several trends are currently shaping the insulin pump industry, reflecting broader healthcare shifts towards digital integration and personalized medicine. There is a growing emphasis on devices that enhance connectivity and patient autonomy, such as pumps that can be controlled via smartphone applications. These apps can track and analyze user data over time, offering personalized insights and sharing information with healthcare providers to improve treatment plans. Another trend is the increasing consumer demand for discreet and convenient devices, leading to the development of smaller, more wearable pumps that offer greater comfort and less intrusion into daily life. Additionally, regulatory bodies and diabetes organizations are advocating for greater access to advanced diabetes management tools, which is influencing insurance policies and subsidy programs to cover more sophisticated, albeit expensive, technologies.

What Drives the Growth of the Insulin Pumps Market?
The growth in the insulin pumps market is driven by several factors, including the rising prevalence of diabetes globally and the increasing awareness of the advantages of pump therapy over traditional injection methods. Advances in technology that enhance the effectiveness, ease of use, and integration with other health management tools are pivotal. The growing acceptance of telemedicine and mobile health applications also supports the expansion of the insulin pump market, as these platforms facilitate remote monitoring and management of diabetes, appealing to a tech-savvy generation. Additionally, improvements in healthcare infrastructure, increasing healthcare expenditure, and expanding private and public insurance coverage for diabetes care encourage the adoption of advanced diabetes care solutions. These dynamics ensure sustained growth and demand for insulin pumps in the healthcare market, improving the lives of diabetes patients worldwide.

Select Competitors (Total 12 Featured) -

• Debiotech S.A.
• F. Hoffmann-La Roche Ltd.
• Insulet Corp.
• Medtronic Plc.
• Sooil Development Co. Ltd.
• Tandem Diabetes Care Inc.
• Valeritas Inc.
• Ypsomed Holding AG

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.